Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Imaging Copper Levels during Life in the Brain and beyond Using a Fluorescent Copper Sensor with Multimodal Capacity.

Chemical & biomedical imaging·2025

Same author

Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model.

Acta neuropathologica communications·2025

Same author

Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model.

Acta neuropathologica·2025

Same author

The background and experience of neuroscience teachers in Australian universities: A cross-sectional survey.

PloS one·2024

Same author

Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu<sup>2+</sup> in the Brain.

ACS sensors·2024

Same author

Responsible research practices could be more strongly endorsed by Australian university codes of research conduct.

Research integrity and peer review·2023

Search research articles

Related Experiment Video

Updated: May 26, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Neuronal vulnerability in Parkinson's disease.

¹Neurosdence Research Australia and University of New South Wales, Sydney, NSW, 2031, Australia. k.double@neura.edu.au

Parkinsonism & Related Disorders

|December 15, 2011

Summary

Neuromelanin, a pigment in Parkinson's disease brain cells, undergoes changes that contribute to neurodegeneration. Alterations in copper levels, not just iron, may also increase neuronal vulnerability in this disorder.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Related Experiment Videos

Last Updated: May 26, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Area of Science:

Neuroscience
Cell Biology
Biochemistry

Background:

Parkinson's disease (PD) involves progressive dopaminergic neuron loss in the substantia nigra.
The selective vulnerability of these neurons remains poorly understood.
Neuromelanin, a pigment in substantia nigra neurons, is implicated in PD pathogenesis.

Purpose of the Study:

To investigate the role of neuromelanin structural changes in Parkinson's disease.
To explore the association between neuromelanin, alpha-synuclein aggregation, and metal binding in PD.
To examine the contribution of copper, in addition to iron, to neuronal vulnerability in PD.

Main Methods:

Analysis of neuromelanin structure and its association with alpha-synuclein in post-mortem Parkinson's disease brain tissue.
Investigation of metal binding properties of neuromelanin.
Assessment of copper and iron levels in relation to neurodegeneration.

Main Results:

Neuromelanin shows structural alterations in the Parkinson's disease brain.
These structural changes are linked to alpha-synuclein protein aggregation, even in early PD stages.
Altered copper levels, alongside iron, are implicated in the vulnerability of dopaminergic neurons.

Conclusions:

Neuromelanin undergoes pathological changes in Parkinson's disease, contributing to neurodegeneration.
Both altered neuromelanin structure and dysregulated metal homeostasis (particularly copper) are key factors in dopaminergic neuron vulnerability in PD.